277 related articles for article (PubMed ID: 28446559)
1. Burden of non-tuberculous mycobacterial pulmonary disease in Germany.
Diel R; Jacob J; Lampenius N; Loebinger M; Nienhaus A; Rabe KF; Ringshausen FC
Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28446559
[TBL] [Abstract][Full Text] [Related]
2. Epidemiology of Adults and Children Treated for Nontuberculous Mycobacterial Pulmonary Disease in Japan.
Izumi K; Morimoto K; Hasegawa N; Uchimura K; Kawatsu L; Ato M; Mitarai S
Ann Am Thorac Soc; 2019 Mar; 16(3):341-347. PubMed ID: 30339468
[TBL] [Abstract][Full Text] [Related]
3. Predictive modeling of nontuberculous mycobacterial pulmonary disease epidemiology using German health claims data.
Ringshausen FC; Ewen R; Multmeier J; Monga B; Obradovic M; van der Laan R; Diel R
Int J Infect Dis; 2021 Mar; 104():398-406. PubMed ID: 33444748
[TBL] [Abstract][Full Text] [Related]
4. Non-tuberculous mycobacterial pulmonary diseases in France: an 8 years nationwide study.
Veziris N; Andréjak C; Bouée S; Emery C; Obradovic M; Chiron R
BMC Infect Dis; 2021 Nov; 21(1):1165. PubMed ID: 34789152
[TBL] [Abstract][Full Text] [Related]
5. Pulmonary Nontuberculous Mycobacteria-Associated Deaths, Ontario, Canada, 2001-2013.
Marras TK; Campitelli MA; Lu H; Chung H; Brode SK; Marchand-Austin A; Winthrop KL; Gershon AS; Kwong JC; Jamieson FB
Emerg Infect Dis; 2017 Mar; 23(3):468-476. PubMed ID: 28221106
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for a one-year improvement in nontuberculous mycobacterial pulmonary disease: An 11-year retrospective and multicenter study.
Cadelis G; Ducrot R; Bourdin A; Rastogi N
PLoS Negl Trop Dis; 2017 Aug; 11(8):e0005841. PubMed ID: 28787454
[TBL] [Abstract][Full Text] [Related]
7. Introducing the new BTS Guideline: Management of non-tuberculous mycobacterial pulmonary disease (NTM-PD).
Haworth CS; Floto RA
Thorax; 2017 Nov; 72(11):969-970. PubMed ID: 29054887
[TBL] [Abstract][Full Text] [Related]
8. Factors which influence treatment initiation for pulmonary non-tuberculous mycobacterium infection in HIV negative patients; a multicentre observational study.
Rawson TM; Abbara A; Kranzer K; Ritchie A; Milburn J; Brown T; Adeboyeku D; Buckley J; Davidson RN; Berry M; Kon OM; John L
Respir Med; 2016 Nov; 120():101-108. PubMed ID: 27817806
[TBL] [Abstract][Full Text] [Related]
9. Risk factors for mortality in patients with pulmonary infections with non-tuberculous mycobacteria: a retrospective cohort study.
Gommans EP; Even P; Linssen CF; van Dessel H; van Haren E; de Vries GJ; Dingemans AM; Kotz D; Rohde GG
Respir Med; 2015 Jan; 109(1):137-45. PubMed ID: 25464905
[TBL] [Abstract][Full Text] [Related]
10. Hospitalization Risk for Medicare Beneficiaries With Nontuberculous Mycobacterial Pulmonary Disease.
Prevots DR; Marras TK; Wang P; Mange KC; Flume PA
Chest; 2021 Dec; 160(6):2042-2050. PubMed ID: 34314672
[TBL] [Abstract][Full Text] [Related]
11. Comorbidities associated with nontuberculous mycobacterial disease in Japanese adults: a claims-data analysis.
Uno S; Asakura T; Morimoto K; Yoshimura K; Uwamino Y; Nishimura T; Hoshino Y; Hasegawa N;
BMC Pulm Med; 2020 Oct; 20(1):262. PubMed ID: 33036598
[TBL] [Abstract][Full Text] [Related]
12. Advances in diagnosis and treatment of non-tuberculous mycobacterial lung disease.
Ying C; Zhang L; Jin X; Zhu D; Wu W
Diagn Microbiol Infect Dis; 2024 Jun; 109(2):116254. PubMed ID: 38492490
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary disease caused by a newly identified mycobacterium: Mycolicibacterium toneyamachuris: a case report.
Kuge T; Fukushima K; Matsumoto Y; Abe Y; Akiba E; Haduki K; Saito H; Nitta T; Kawano A; Kawasaki T; Matsuki T; Kagawa H; Motooka D; Tsujino K; Miki M; Miki K; Kitada S; Nakamura S; Iida T; Kida H
BMC Infect Dis; 2020 Nov; 20(1):888. PubMed ID: 33238934
[TBL] [Abstract][Full Text] [Related]
14. Intersectoral Cost of Treating Pulmonary Non-Tuberculosis Mycobacterial Disease (NTM-PD) in Germany-A Change of Perspective in Disease Management.
Diel R; Mertsch P
Int J Environ Res Public Health; 2019 Oct; 16(20):. PubMed ID: 31600981
[TBL] [Abstract][Full Text] [Related]
15. Meeting the challenges of NTM-PD from the perspective of the organism and the disease process: innovations in drug development and delivery.
van der Laan R; Snabilié A; Obradovic M
Respir Res; 2022 Dec; 23(1):376. PubMed ID: 36566170
[TBL] [Abstract][Full Text] [Related]
16. Costs Associated with Nontuberculous Mycobacteria Infection, Ontario, Canada, 2001-2012.
Ramsay LC; Shing E; Wang J; Marras TK; Kwong JC; Brode SK; Jamieson FB; Sander B
Emerg Infect Dis; 2020 Sep; 26(9):2097-2107. PubMed ID: 32818392
[TBL] [Abstract][Full Text] [Related]
17. Management of nontuberculous mycobacterial (NTM) lung disease.
Philley JV; Griffith DE
Semin Respir Crit Care Med; 2013 Feb; 34(1):135-42. PubMed ID: 23460013
[TBL] [Abstract][Full Text] [Related]
18. Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report.
Addy C; Doran G; Jones AL; Wright G; Caskey S; Downey DG
BMC Pulm Med; 2018 Nov; 18(1):170. PubMed ID: 30453935
[TBL] [Abstract][Full Text] [Related]
19. Guidelines-based treatment associated with improved economic outcomes in nontuberculous mycobacterial lung disease.
Marras TK; Mirsaeidi M; Vinnard C; Chan ED; Eagle G; Zhang R; Wang P; Zhang Q
J Med Econ; 2019 Nov; 22(11):1126-1133. PubMed ID: 31094592
[No Abstract] [Full Text] [Related]
20. Non-tuberculous mycobacterial infection among lung transplant recipients: a 15-year cohort study.
Knoll BM; Kappagoda S; Gill RR; Goldberg HJ; Boyle K; Baden LR; Fuhlbrigge AL; Marty FM
Transpl Infect Dis; 2012 Oct; 14(5):452-60. PubMed ID: 22676720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
